152 related articles for article (PubMed ID: 28231593)
1. Long-Term Relief of Cerebral Radiation Necrosis Treated with Low-Dose Bevacizumab - a Report of 2 Cases.
Hu Q; Zhao J; Xu J; Zhou X; Shui Y; Shen L; Wei Q
Oncol Res Treat; 2017; 40(3):133-137. PubMed ID: 28231593
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab alleviates radiation-induced brain necrosis: A report of four cases.
Xiang-Pan L; Yuxin C; Xiao-Fei W; Na L; Tang-Peng X; Xiao-Tao X; Chang-Li R; Wei-Guo H; Qi-Bin S
J Cancer Res Ther; 2015; 11(2):485-7. PubMed ID: 26148625
[TBL] [Abstract][Full Text] [Related]
3. Effect of bevacizumab on radiation necrosis of the brain.
Gonzalez J; Kumar AJ; Conrad CA; Levin VA
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):323-6. PubMed ID: 17236958
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis.
Yonezawa S; Miwa K; Shinoda J; Nomura Y; Asano Y; Nakayama N; Ohe N; Yano H; Iwama T
J Neurooncol; 2014 Aug; 119(1):101-9. PubMed ID: 24789256
[TBL] [Abstract][Full Text] [Related]
5. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
Furuse M; Kawabata S; Kuroiwa T; Miyatake S
J Neurooncol; 2011 May; 102(3):471-5. PubMed ID: 20694573
[TBL] [Abstract][Full Text] [Related]
6. Indication of Bevacizumab for Cerebral Radiation Necrosis.
Zhuang H; Yuan X; Yuan Z; Wang P
Recent Pat Anticancer Drug Discov; 2017; 12(3):272-277. PubMed ID: 28443515
[TBL] [Abstract][Full Text] [Related]
7. Single-shot bevacizumab for cerebral radiation injury.
Voss M; Wenger KJ; Fokas E; Forster MT; Steinbach JP; Ronellenfitsch MW
BMC Neurol; 2021 Feb; 21(1):77. PubMed ID: 33596839
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab for the Treatment of Gammaknife Radiosurgery-Induced Brain Radiation Necrosis.
Ma Y; Zheng C; Feng Y; Xu Q
J Craniofac Surg; 2017 Sep; 28(6):e569-e571. PubMed ID: 28749838
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of repeated low-dose bevacizumab treatment with long-dosing interval for radiation-induced brain necrosis: A case report.
Meng X; Zhao R; Wu S; Shen G; Ding L; Sun B; Wang J
Cancer Biol Ther; 2017 Jan; 18(1):63-66. PubMed ID: 28152324
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
[TBL] [Abstract][Full Text] [Related]
11. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
Levin VA; Bidaut L; Hou P; Kumar AJ; Wefel JS; Bekele BN; Grewal J; Prabhu S; Loghin M; Gilbert MR; Jackson EF
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1487-95. PubMed ID: 20399573
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis.
Bodensohn R; Hadi I; Fleischmann DF; Corradini S; Thon N; Rauch J; Belka C; Niyazi M
Strahlenther Onkol; 2020 Jan; 196(1):70-76. PubMed ID: 31586230
[TBL] [Abstract][Full Text] [Related]
13. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PET.
Furuse M; Nonoguchi N; Kawabata S; Yoritsune E; Takahashi M; Inomata T; Kuroiwa T; Miyatake S
Jpn J Clin Oncol; 2013 Mar; 43(3):337-41. PubMed ID: 23303838
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.
Liu AK; Macy ME; Foreman NK
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1148-54. PubMed ID: 19857784
[TBL] [Abstract][Full Text] [Related]
16. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.
Wang Y; Pan L; Sheng X; Mao Y; Yao Y; Wang E; Zhang N; Dai J
Eur J Med Res; 2012 Aug; 17(1):25. PubMed ID: 22913802
[TBL] [Abstract][Full Text] [Related]
17. A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis.
Zhuang H; Yuan X; Zheng Y; Li X; Chang JY; Wang J; Wang X; Yuan Z; Wang P
Sci Rep; 2016 Apr; 6():24364. PubMed ID: 27067388
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of bevacizumab for radiation-induced cerebral necrosis in children.
Preuss M; Hirsch W; Hoffmann KT; Bernhard MK; Siekmeyer M; Kiess W; Meixensberger J; Wurm RE; Merkenschlager A
Pediatr Neurosurg; 2013; 49(2):81-5. PubMed ID: 24435068
[TBL] [Abstract][Full Text] [Related]
19. Exacerbation of cerebral radiation necrosis by bevacizumab.
Jeyaretna DS; Curry WT; Batchelor TT; Stemmer-Rachamimov A; Plotkin SR
J Clin Oncol; 2011 Mar; 29(7):e159-62. PubMed ID: 21149667
[No Abstract] [Full Text] [Related]
20. Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.
Dashti SR; Kadner RJ; Folley BS; Sheehan JP; Han DY; Kryscio RJ; Carter MB; Shields LBE; Plato BM; La Rocca RV; Spalding AC; Yao TL; Fraser JF
J Neurosurg; 2022 Dec; 137(6):1676-1686. PubMed ID: 35426830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
